Načítá se...
A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm with 5-year survival as low as 6%. It is therefore imperative to explore potential treatment avenues to improve survival in these groups of patients. Anti-estrogenic hormone therapy (AEHT) is well-tolerated an...
Uloženo v:
| Vydáno v: | Transl Gastroenterol Hepatol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724184/ https://ncbi.nlm.nih.gov/pubmed/33409403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2020.02.16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|